Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Peregrine Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00677716
First received: May 12, 2008
Last updated: April 23, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2011
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)